Shagun Singh
Stock Analyst at RBC Capital
(2.39)
# 2,425
Out of 4,714 analysts
183
Total ratings
44.23%
Success rate
-1.85%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterates: Outperform | $400 → $425 | $361.52 | +17.56% | 17 | Dec 11, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $80 → $85 | $73.91 | +15.00% | 20 | Dec 5, 2024 | |
| NVRO Nevro | Reiterates: Sector Perform | $7 | $3.71 | +88.68% | 9 | Nov 12, 2024 | |
| GMED Globus Medical | Maintains: Outperform | $80 → $92 | $82.79 | +11.12% | 5 | Nov 6, 2024 | |
| INSP Inspire Medical Systems | Reiterates: Outperform | $260 | $198.68 | +30.86% | 3 | Nov 5, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $120 → $125 | $104.47 | +19.65% | 12 | Nov 4, 2024 | |
| TFX Teleflex | Maintains: Outperform | $275 → $245 | $181.75 | +34.80% | 19 | Nov 1, 2024 | |
| DXCM DexCom | Maintains: Outperform | $120 → $115 | $81.07 | +41.85% | 4 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $95 → $98 | $90.69 | +8.06% | 13 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $525 → $555 | $535.30 | +3.68% | 13 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $144.19 | +25.53% | 15 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $98 → $105 | $80.95 | +29.71% | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $11 | $8.09 | +35.97% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $205 → $222 | $241.97 | -8.25% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $130 | $113.83 | +14.21% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $36.83 | +76.49% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $6 → $3 | $1.40 | +114.29% | 8 | Aug 8, 2024 |
Stryker
Dec 11, 2024
Reiterates: Outperform
Price Target: $400 → $425
Current: $361.52
Upside: +17.56%
Edwards Lifesciences
Dec 5, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $73.91
Upside: +15.00%
Nevro
Nov 12, 2024
Reiterates: Sector Perform
Price Target: $7
Current: $3.71
Upside: +88.68%
Globus Medical
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $82.79
Upside: +11.12%
Inspire Medical Systems
Nov 5, 2024
Reiterates: Outperform
Price Target: $260
Current: $198.68
Upside: +30.86%
Zimmer Biomet Holdings
Nov 4, 2024
Maintains: Outperform
Price Target: $120 → $125
Current: $104.47
Upside: +19.65%
Teleflex
Nov 1, 2024
Maintains: Outperform
Price Target: $275 → $245
Current: $181.75
Upside: +34.80%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $81.07
Upside: +41.85%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $95 → $98
Current: $90.69
Upside: +8.06%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $525 → $555
Current: $535.30
Upside: +3.68%
Oct 16, 2024
Maintains: Outperform
Price Target: $178 → $181
Current: $144.19
Upside: +25.53%
Oct 10, 2024
Upgrades: Outperform
Price Target: $98 → $105
Current: $80.95
Upside: +29.71%
Oct 8, 2024
Maintains: Outperform
Price Target: $12 → $11
Current: $8.09
Upside: +35.97%
Oct 8, 2024
Maintains: Outperform
Price Target: $205 → $222
Current: $241.97
Upside: -8.25%
Oct 8, 2024
Maintains: Outperform
Price Target: $125 → $130
Current: $113.83
Upside: +14.21%
Oct 2, 2024
Initiates: Outperform
Price Target: $65
Current: $36.83
Upside: +76.49%
Aug 8, 2024
Downgrades: Sector Perform
Price Target: $6 → $3
Current: $1.40
Upside: +114.29%